Last week’s significant research news included Revolution Medicines presenting new data on its cancer drug Rasonque in KRAS ...

The US Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would improve the accuracy of provider ...

German biotech BioNTech (Nasdaq: BNTX) has reported a setback for its experimental mRNA cancer immunotherapy BNT113 ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended four novel medicines and two biosimilars ...

US genetic medicines developer Estuary Biotherapeutics today announced its launch with $103 million in total committed ...

US healthcare investment firm OrbiMed has raised $3 billion in commitments for two funds targeting companies across the USA, ...

Singapore based clinical-stage biotech Adlai Nortye Group has entered into clinical trial collaboration and supply agreements ...

US drugmaker Ironwood Pharmaceuticals, which is focused on gastrointestinal and rare diseases, has announced a leadership ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) today authorised Onswik (insulin efsitora alfa) for the ...

Belgian biotech Lakefront Biotherapeutics (Euronext: LKFT), formerly Galapagos, has sold its preclinical cell therapy ...

Fractyl Health today announced top-line six-month results from the Pivotal Cohort of its ongoing REMAIN-1 study (Pivotal ...

US biotech company Iambic Therapeutics (Nasdaq: IAM) has priced a $150 million initial public offering (IPO), securing ...